Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 114 publications
Adverse Events in a Randomized Trial Comparing Radiotherapy with or without Olaparib for Inflammatory Breast Cancer.
Journal: International journal of radiation oncology, biology, physics
Published: April 13, 2026
Survival and Treatment Patterns in Stage III Inflammatory and Noninflammatory Breast Cancer.
Journal: JAMA network open
Published: April 09, 2026
ASO Visual Abstract: Evaluating the Impact of a Surgeon-Led Ductal Carcinoma In Situ Program on Endocrine Therapy Uptake.
Journal: Annals of surgical oncology
Published: February 25, 2026
ASO Visual Abstract: Breast-Conserving Therapy for Multiple Ipsilateral Breast Cancer After Neoadjuvant Systemic Therapy.
Journal: Annals of surgical oncology
Published: February 09, 2026
Pathological complete response with neoadjuvant pembrolizumab and chemotherapy in non-metastatic triple-negative inflammatory breast cancer.
Journal: ESMO open
Published: November 04, 2025
Breast-Conserving Therapy for Multiple Ipsilateral Breast Cancer After Neoadjuvant Systemic Therapy.
Breast-Conserving Therapy for Multiple Ipsilateral Breast Cancer After Neoadjuvant Systemic Therapy.
Journal: Annals of surgical oncology
Published: September 30, 2025
Evaluating the Impact of a Surgeon-Led Ductal Carcinoma in Situ Program on Endocrine Therapy Uptake.
Evaluating the Impact of a Surgeon-Led Ductal Carcinoma in Situ Program on Endocrine Therapy Uptake.
Journal: Annals of surgical oncology
Published: September 17, 2025
Outcomes of patients with de novo oligometastatic breast cancer treated with curative intent at a single institution.
Journal: Breast cancer research and treatment
Published: September 10, 2025
The Clinicopathologic Features of Inflammatory Breast Carcinoma (IBC) With Lobular Features.
Journal: The American journal of surgical pathology
Published: July 03, 2025
Management of ipsilateral breast tumor recurrence after prior breast conservation therapy.
Journal: Breast cancer research and treatment
Published: March 18, 2025
Neoadjuvant therapy with eribulin, doxorubicin and cyclophosphamide for patients with HER2-negative inflammatory breast cancer: a phase II study.
Journal: Breast cancer research : BCR
Published: January 30, 2025
Awareness, Knowledge, and Treatment Patterns of Nonmetastatic Inflammatory Breast Cancer in Low- and Middle-Income Countries: The BRIDGES Study.
Journal: JCO global oncology
Published: December 20, 2024
Last Updated: 09/26/2026